WO2007133820A3 - Diaryl triazolones as cb1 antagonists - Google Patents
Diaryl triazolones as cb1 antagonists Download PDFInfo
- Publication number
- WO2007133820A3 WO2007133820A3 PCT/US2007/060599 US2007060599W WO2007133820A3 WO 2007133820 A3 WO2007133820 A3 WO 2007133820A3 US 2007060599 W US2007060599 W US 2007060599W WO 2007133820 A3 WO2007133820 A3 WO 2007133820A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- diaryl
- triazolones
- disorders
- compounds
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Diaryl triazolones of Formula I are provided, in which the variables are as described herein. Such compounds may be used to modulate CB1 activity in vivo or in vitro, and are particularly useful in the treatment of conditions responsive to CB1 modulation in humans, domesticated companion animals and livestock animals, including appetite disorders, obesity and addictive disorders. Pharmaceutical compositions and methods for using diaryl traizolones of Formula I to treat such disorders are provided, as are methods for using such compounds as ligands for receptor localization studies and various in vitro assays.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US76012306P | 2006-01-19 | 2006-01-19 | |
US60/760,123 | 2006-01-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007133820A2 WO2007133820A2 (en) | 2007-11-22 |
WO2007133820A3 true WO2007133820A3 (en) | 2008-08-28 |
Family
ID=38694569
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/060599 WO2007133820A2 (en) | 2006-01-19 | 2007-01-17 | Diaryl triazolones as cb1 antagonists |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2007133820A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2025674A1 (en) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituted tetra hydro naphthalines, method for their manufacture and their use as drugs |
EP2683699B1 (en) | 2011-03-08 | 2015-06-24 | Sanofi | Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
US8871758B2 (en) | 2011-03-08 | 2014-10-28 | Sanofi | Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
US8828995B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
WO2012120052A1 (en) | 2011-03-08 | 2012-09-13 | Sanofi | Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof |
WO2012120054A1 (en) | 2011-03-08 | 2012-09-13 | Sanofi | Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6258957B1 (en) * | 1995-06-09 | 2001-07-10 | Bayer Aktiengesellschaft | N-aryl-1,2,4-triazolin-5-ones |
-
2007
- 2007-01-17 WO PCT/US2007/060599 patent/WO2007133820A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6258957B1 (en) * | 1995-06-09 | 2001-07-10 | Bayer Aktiengesellschaft | N-aryl-1,2,4-triazolin-5-ones |
Non-Patent Citations (1)
Title |
---|
ENDERS ET AL.: "Preparation and Application of 1,3,4-Triphenyl-4,5-dihydro-1H-1,2,4-triazol-5-ylidene, A Stable Carbene", vol. 8, February 2003 (2003-02-01), pages 1292 - 1295 * |
Also Published As
Publication number | Publication date |
---|---|
WO2007133820A2 (en) | 2007-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006049941A3 (en) | Diaryl ureas as cb1 antagonists | |
TW200716594A (en) | Substituted heteroaryl CB1 antagonists | |
WO2006052542A3 (en) | Arylalkyl ureas as cb1 antagonists | |
WO2007146761A3 (en) | Diaryl pyrimidinones and related compounds | |
WO2009012482A3 (en) | 5-membered heterocyclic amides and related compounds | |
WO2008016811A3 (en) | Aminopiperidines and realted compounds | |
WO2007133561A3 (en) | Substituted azaspiro derivatives | |
WO2008066789A3 (en) | Heteroaryl amide derivatives | |
WO2006078992A3 (en) | Heteroaryl substituted piperazinyl-pyridine analogues | |
WO2005110982A3 (en) | Substituted 1-benzyl-4-substituted piperazine analogues | |
MY148461A (en) | Heteroaryl amide analogues as p2x7 antagonists | |
WO2006026135A3 (en) | Substituted biaryl piperazinyl-pyridine analogues | |
WO2007101007A3 (en) | Aryl sulfonyl heterocycles | |
WO2007140383A3 (en) | Spirocyclic sulfonamides and related compounds | |
WO2006076646A3 (en) | Heteroaryl substituted quinolin-4-ylamine analogues | |
WO2006081388A3 (en) | Substituted pyridazinyl-and pyrimidinyl-quinolin-4-ylamine analogues | |
WO2007106349A3 (en) | Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues | |
WO2005042498A3 (en) | 4-amino (aza) quinoline derivatives as capsaicin receptor agonists | |
WO2006042289A3 (en) | Substituted biaryl quinolin-4-ylamine analogues | |
WO2006089076A3 (en) | Thiazole amides, imidazole amides and related analogues | |
WO2005007648A3 (en) | Biaryl piperazinyl-pyridine analogues | |
WO2008024433A3 (en) | Haloalkyl-substituted pyrimidinone derivatives | |
WO2005007652A3 (en) | Substituted quinolin-4-ylamine analogues | |
WO2008024438A3 (en) | 2-phenoxy pyrimidinone analogues | |
WO2008033739A3 (en) | Benzimidazole carboxamide derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07811784 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07811784 Country of ref document: EP Kind code of ref document: A2 |